Načítá se...

Denosumab reduces early migration in total knee replacement: A randomized controlled trial involving 50 patients

BACKGROUND AND PURPOSE: Aseptic loosening is a main cause of late revision in total knee replacement (TKR). Migration of implants as measured by radiostereometric analysis (RSA) can predict future loosening. This migration is associated with bone resorption. Denosumab is a human monoclonal antibody...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Orthop
Hlavní autoři: Ledin, Håkan, Good, Lars, Aspenberg, Per
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434591/
https://ncbi.nlm.nih.gov/pubmed/28287004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17453674.2017.1300746
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!